Frontiers in Cardiovascular Medicine

JANUARY 21, 2025

Atrial fibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. It can be associated with reduced quality of life and complications such as heart failure and stroke. Pulmonary vein isolation (PVI) is the most effective treatment for rhythm control.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Ablation Electrophysiology 52

European Journal of Heart Failure

MARCH 19, 2025

Abstract Patients presenting with or alerting emergency networks due to acute heart failure (AHF) form a diverse group with a plethora of symptoms, risks, comorbidities, and aetiologies. Scientific guidelines provide clear recommendations for the management of arrhythmias in chronic heart failure patients.

Heart Failure 40

Heart Failure Cardiogenic Shock Arrhythmia Heart Rhythm 40

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2024

Heart failure (HF) is recognized as an epidemic in the contemporary world, impacting around 1%–2% of the adult population and affecting around 6 million Americans. Among the most serious manifestations associated with HF is arrhythmia due to the electrophysiological changes within the cardiomyocyte.

Heart Failure 64

Heart Failure Electrophysiology Quality of Life Arrhythmia 64

Heart BMJ

DECEMBER 23, 2024

However, despite intervention according to these recommendations, patients remain at risk of post-operative heart failure and mortality.

Bicuspid/Mitral 59

Bicuspid/Mitral Atrial Fibrillation Heart Failure Pulmonary 59

Ken Grauer, MD

SEPTEMBER 15, 2024

For full discussion of the case — CLICK HERE — ECG Rhythm Overview: A 12-year-old boy was admitted to our hospital with severe myocardial dysfunction and chaotic rhythm with tachy- and bradycardic arrhythmias. Hope this helps — :) ECG-3 — I see sinus bradycardia and arrhythmia.

Arrhythmia 78

Arrhythmia Bradycardia Heart Failure Pacemaker 78

European Journal of Heart Failure

FEBRUARY 5, 2025

Methods and results TRED-HF was a randomized trial investigating heart failure therapy withdrawal in patients with recovered DCM over 6months. The primary outcome was relapse defined as 10% reduction in left ventricular ejection fraction to 400ng/L, or clinical features of heart failure.

Heart Failure 67

Heart Failure Cardiomyopathy Atrial Fibrillation Arrhythmia 67

Journal of Cardiovascular Electrophysiology

NOVEMBER 29, 2023

Abstract Left ventricular assist device (LVAD) implantation is an established treatment for patients with advanced heart failure refractory to medical therapy. However, the incidence of ventricular arrhythmias (VAs) is high in this population, both in the acute and delayed phases after implantation.

Arrhythmia 75

Arrhythmia Heart Failure Ablation Outcomes 75

European Journal of Heart Failure

DECEMBER 18, 2024

Impact of guideline-directed medical therapy for heart failure after left ventricular ejection fraction (LVEF) improvement in arrhythmia-induced cardiomyopathy. ( A ) Study flow chart. ( B ) Changes in renin-angiotensin-system (RAS) inhibitors and beta-blockers (BB) prescriptions after LVEF improvement. (

Heart Failure 40

Heart Failure Arrhythmia Cardiomyopathy Research 40

HeartRhythm

SEPTEMBER 4, 2023

An abnormal myocardial Ca2+ transient is linked to heart failure and ventricular arrhythmias. This narrative review evaluates the role of aberrant Ca2+ release synchrony in the pathophysiology of cardiomyopathies and ventricular arrhythmias.

Heart Failure 40

Heart Failure Arrhythmia Electrophysiology Cardiomyopathy 40

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. 111.87), arrhythmias were detected in 9 (33%) patients. We did not identify significant risk factors for arrhythmias post-HT.

Heart Transplant 59

Heart Transplant Transplant Arrhythmia Pacemaker 59

HeartRhythm

JULY 21, 2024

The global health challenge posed by cardiac arrhythmias, particularly atrial fibrillation (AF), is significant, with heightened risks of stroke, heart failure, and systemic embolism1.

Technology 45

Technology Arrhythmia Atrial Fibrillation Heart Failure 45

DAIC

MAY 30, 2024

Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias. Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern.

Technology 105

Technology Heart Rhythm Hospital Cardiac Arrest 105

HeartRhythm

APRIL 30, 2024

The progression of heart failure (HF) is associated with detrimental myocardial structural changes, predisposing HF patients to an increased risk of ventricular arrhythmia (VA).

Heart Failure 40

Heart Failure Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Genetic predisposition to ventricular scarring is associated with heart failure and ventricular arrhythmia. Although many pathogenic variants have been shown to predispose patients to poor outcomes, the impact of many VUS remains uncharacterized.

Genetic predisposition 40

Genetic predisposition Heart Failure Arrhythmia Cardiomyopathy 40

The American Journal of Cardiology

JUNE 11, 2024

Publication date: Available online 11 June 2024 Source: The American Journal of Cardiology Author(s): Steven Brady, Eldon Matthia, Steve Antoine, Juan Aranda, William Miles, Juan Vilaro, Mohammad Al-Ani, Olusola Oduntan, Yi Guo, Yujia Li, Mustafa Ahmed, Alex Parker

Heart Failure 52

Heart Failure Arrhythmia Outcomes 52

Cardiology Update

JANUARY 12, 2025

Hashtag: #ACC25 European Heart Rhythm Association (EHRA) Congress 2025 Date: 30 March to 1 April 2025 Location: Vienna and online Overview: The yearly gathering of the European Heart Rhythm Association (EHRA) unites scientists, healthcare professionals, and other stakeholders engaged in the global management of arrhythmias.

Heart Failure 52

Heart Failure Atherosclerosis Heart Rhythm Nursing 52

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background Echocardiography-guided percutaneous intramyocardial alginate-hydrogel implantation (PIMAHI) is a novel treatment approach for heart failure (HF). During PIMAHI treatment, no sustained arrhythmia, pericardial, or pleural effusion occurred. We validated PIMAHI safety and efficacy in canine HF models. vs. 6.8 ± 0.2 mm,

Heart Failure 64

Heart Failure Outcomes Bicuspid/Mitral Arrhythmia 64

European Journal of Heart Failure

FEBRUARY 25, 2025

Abstract Aims The CASTLE-HTx trial showed the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device implantation or heart transplantation (HTx) in patients with end-stage heart failure (HF).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

NEJM Journal Watch - Cardiology

MAY 11, 2024

Clinicians should have a high degree of suspicion for cardiac sarcoidosis in patients with new heart failure, high-grade conduction disease, ventricular arrhythmias, and known extracardiac disease.

Heart Failure 71

Heart Failure Arrhythmia 71

Medical Xpress - Cardiology

SEPTEMBER 13, 2024

Atrial fibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heart failure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.

Atrial Fibrillation 75

Atrial Fibrillation Blood Clot AFIB Heart Rhythm 75

Heart BMJ

MAY 10, 2024

Arrhythmias, and in particular atrial fibrillation (AF), are one of the greatest healthcare challenges of our time. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction.

Arrhythmia 40

Arrhythmia Myocardial Infarction Atrial Fibrillation Heart Failure 40

HeartRhythm

APRIL 30, 2024

Cardiac resynchronization (CRT) with biventricular pacing (BVP) is recognized as an option to reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF). Left bundle branch area pacing (LBBAP) is an emerging role in achieving resynchronization in HFrEF and is thought to be a safe alternative to BVP.

Heart Failure 40

Heart Failure Arrhythmia Atrial Fibrillation Defibrillator 40

HeartRhythm

OCTOBER 7, 2024

Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.

Heart Transplant 40

Heart Transplant Transplant Arrhythmia Cardiac Arrest 40

HeartRhythm

JANUARY 6, 2025

Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). Catheter ablation of AF has been proven to be an effective therapeutic option for AF management in HF, particularly in heart failure with reduced ejection fraction (HFrEF) [2, 3].

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

European Journal of Heart Failure

APRIL 1, 2025

Abstract The management of heart failure patients with continuous-flow left ventricular assist device (LVAD) patients is challenging. While one third of these patients are recipients of cardiac implantable electronic devices (CIEDs), the risk for atrial and ventricular arrhythmias may coexist.

Heart Rhythm 40

Heart Rhythm Heart Failure Arrhythmia 40

Cardiology Update

JANUARY 2, 2024

European Heart Rhythm Association (EHRA) Congress Date: April 7-9, 2024 Location: Berlin, Germany and online Overview: The yearly gathering of the European Heart Rhythm Association (EHRA) unites scientists, healthcare professionals, and other stakeholders engaged in the global management of arrhythmias. Hashtag: #ESCPrev2024 5.

Heart Failure 111

Heart Failure Atherosclerosis Cardiovascular Imaging Non-Invasive Cardiology 111

HeartRhythm

APRIL 30, 2024

Ventricular arrhythmias and heart failure are common presentations of cardiac sarcoidosis (CS). Guidelines support implantable cardioverter-defibrillator (ICD) for many CS patients with reduced ejection fraction, but arrhythmic outcomes are poorly understood.

Defibrillator 40

Defibrillator Heart Failure Arrhythmia Outcomes 40

HeartRhythm

APRIL 30, 2024

Cardiac resynchronization therapy (CRT) is cornerstone of device therapy in heart failure (HF). Arrhythmia is associated with significant morbidity and mortality in patients with HF. However, risk of arrhythmia in patients with LBBAP in comparison to biventricular pacing (BiVP) CRT is unclear.

Arrhythmia 40

Arrhythmia Heart Failure 40

DAIC

DECEMBER 27, 2023

With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias. “We For more information: www.stereotaxis.com If you enjoy this content, please share it with a colleague

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

DAIC

JUNE 11, 2024

“With the Genesis RMN system, we now have an unprecedented level of precision and control during cardiac ablation procedures, allowing us to target arrhythmias with unmatched accuracy while minimizing risk to our patients.” added Giuseppe Russo, General Manager of the Hospital Santa Maria della Pietà.

Heart Rhythm 81

Heart Rhythm Technology Electrophysiology Arrhythmia 81

Circulation

FEBRUARY 4, 2024

Circulation, Volume 149, Issue 6 , Page 475-480, February 6, 2024.

Heart Failure 49

Heart Failure Arrhythmia Circulation 49

Journal of the American Heart Association

MARCH 21, 2025

Journal of the American Heart Association, Ahead of Print. BackgroundCarotid intimamedia thickness (CIMT) and carotid distensibility are markers of arterial change; however, little is known of the association with incident heart failure (HF).

Heart Failure 40

Heart Failure Myocardial Infarction Arrhythmia Diabetes 40

The British Journal of Cardiology

AUGUST 21, 2024

Digoxin has been used in the management of chronic heart failure (HF) and atrial fibrillation (AF) for over 250 years. However, due to concerns about arrhythmia and toxicity, its use has declined dramatically over recent decades. It is the only drug that combines an inotropic effect with a reduction in ventricular rate in AF.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Preserved Ejection Fraction Quality of Life 40

Dr. Smith's ECG Blog

JANUARY 2, 2025

Permanent pacer placement Later, a biventricular pacer was placed for " Cardiac Resynchronization Therapy (CRT) " (This is indicated for patients with LBBB and QRS duration > 130 ms and heart failure and vastly improves heart failure). See Dr. Karim's further thoughts on this below.

Tachycardia 116

Tachycardia Cardiomyopathy Blog Bradycardia 116

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

Open Heart

DECEMBER 6, 2023

Although several studies have reported on estimating the risk of developing fatal arrhythmias from ECG findings, the use of ECG to identify the severity of heart failure (HF) by applying deep learning (DL) methods has not been established. Objectives In hypertrophic cardiomyopathy (HCM), specific ECG abnormalities are observed.

Heart Failure 52

Heart Failure Cardiomyopathy Electrocardiogram Arrhythmia 52

Cardiovascular Diabetology

OCTOBER 18, 2024

Type 2 diabetes mellitus (T2DM) is a major risk factor for heart failure with preserved ejection fraction and cardiac arrhythmias. Precursors of these complications, such as diabetic cardiomyopathy, remain inc.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Diabetes Heart Failure Risk Factors 52